VRNA Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 113029 min ago

@ $17.52

Wydano: 14 vas. 2024 @ 22:40

Zwrot: -10.10%

Poprzedni sygnał: vas. 14 - 16:30

Poprzedni sygnał: Sprzedaż

Zwrot: 1.15 %

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 23:00):

Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs...

Stats
Dzisiejszy wolumen	623 199
Średni wolumen	442 936
Kapitalizacja rynkowa	1.22B
EPS	$0 ( 2024-02-29 )
Następna data zysków	( $-0.240 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-21.87
ATR14	$0.0150 (0.10%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-29	Sinha Vikas	Buy	240 000	Share Options (Right to Buy)
2024-04-29	Edwards Martin	Buy	240 000	Share Options (Right to Buy)
2024-04-29	Ullman Anders	Buy	240 000	Share Options (Right to Buy)
2024-04-29	Ebsworth David R	Buy	240 000	Share Options (Right to Buy)
2024-04-29	Ackermann Christina	Buy	240 000	Share Options (Right to Buy)

INSIDER POWER
15.91
Last 97 transactions
Buy: 8 767 528 \| Sell: 8 617 986

Wolumen Korelacja

Długi: -0.42 (neutral)

Krótki: -0.15 (neutral)

Signal:(42.281) Neutral

Verona Pharma plc Korelacja

10 Najbardziej pozytywne korelacje
SIOX	0.953
BWEN	0.952
ECHO	0.952
MLVF	0.951
IIN	0.95
AMYT	0.947
EXAS	0.943
NWLI	0.939
CDZI	0.936
EEFT	0.93

10 Najbardziej negatywne korelacje
PCRX	-0.936
SNPX	-0.935
KPTI	-0.93
HMNF	-0.93
LARK	-0.927
UTME	-0.926
SGLB	-0.918
OP	-0.909
BCAB	-0.909
VNDA	-0.909

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Verona Pharma plc Korelacja - Waluta/Towar

0.79
( moderate )

0.83
( strong )

0.00
( neutral )

0.49
( neutral )

-0.27
( neutral )

-0.65
( weak negative )

Verona Pharma plc Finanse

Annual	2023
Przychody:	$0
Zysk brutto:	$-679 624 (0.00 %)
EPS:	$-0.690

FY	2023
Przychody:	$0
Zysk brutto:	$-679 624 (0.00 %)
EPS:	$-0.690

FY	2022
Przychody:	$458 000
Zysk brutto:	$112 000 (24.45 %)
EPS:	$-1.040

FY	2021
Przychody:	$40.00M
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-0.960

Financial Reports:

No articles found.

Verona Pharma plc

Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. It is developing ensifentrine in three formulations, including nebulizer, dry powder inhaler, and pressurized metered-dose inhaler. Verona Pharma plc was incorporated in 2005 and is headquartered in London, the United Kingdom.